Trial intelligence / Profile preview

Lamotrigine for borderline personality disorder

2012-003136-23Phase 4Completed

Sponsor
Imperial College London
Start
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lamotrigine in borderline personality disorder (BPD), sponsored by Imperial College London. Started Nov 2012; status: completed.

02

Drugs

lamotrigine
03

Conditions

borderline personality disorder (BPD)

Beyond the preview

Go deeper on 2012-003136-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-003136-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call